SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-20-005543
Filing Date
2020-05-07
Accepted
2020-05-07 07:31:49
Documents
49
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 6-K prqr-20200331x6k.htm 6-K 25442
2 EX-99.1 prqr-20200331ex99111a989.htm EX-99.1 670136
3 EX-99.2 prqr-20200331ex9928abede.htm EX-99.2 623672
4 GRAPHIC prqr20200331ex9928abede001.jpg GRAPHIC 54662
5 GRAPHIC prqr20200331ex9928abede002.jpg GRAPHIC 54662
  Complete submission text file 0001558370-20-005543.txt   2893542

Data Files

Seq Description Document Type Size
6 EX-101.INS prqr-20200331.xml EX-101.INS 235672
7 EX-101.SCH prqr-20200331.xsd EX-101.SCH 33452
8 EX-101.CAL prqr-20200331_cal.xml EX-101.CAL 32465
9 EX-101.DEF prqr-20200331_def.xml EX-101.DEF 52519
10 EX-101.LAB prqr-20200331_lab.xml EX-101.LAB 220533
11 EX-101.PRE prqr-20200331_pre.xml EX-101.PRE 141600
Mailing Address DARWINWEG 24 LEIDEN P7 2333CR
Business Address DARWINWEG 24 LEIDEN P7 2333CR 31(0)88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 20854580
SIC: 2834 Pharmaceutical Preparations